2Wallrapp C, Hahnel S, Boeck W, et al. Loss of Y chromosome is a frequent chromosomal imbalance in pancreatic cancer and allows differentiation to chronic pancreatitis. Int J Cancer,2001,91:340- 344.
3Sauter G, Moch H, Wagner U,et al. Y chromosome loss detected by FISH in bladder cancer. Cancer Genet Cytogenet, 1995,82: 163-169.
4OgurG, Duru F, Ozyurek E, et al. t(6;9) (p23;q3g) presenting acute myeloid leukemia in a child with an unsuspected 45, X/46, X, derY [ .9 t ( Yp ; Yq ) ] chromosomal constitution : yetanother Y chromosome overdosage and malignnacy association. Pediatr Hematol Onco1,2012 ,34 :237-240.
5Jankowska AM, Makishima H, Tiu RV, et al. Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A. Blood, 2011, 118: 3932-3941.
6Such E, Germing U, Malcovati L, et al. Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia. Blood, 2013, 121:3005-3015.a. Nature, 2011, 478: 64-69.
7Yoshida K, Sanada M, Shiraishi Y, et al. Frequent pathway mutations of splicing machinery in myelodysplasi.
8Tien HF, Wang CH, Chuang SM, et al. Acute leukemic transformation of myelodysplastic syndrome-immunopheno- typic, genotypic, and cytogenetic studies. Leuk Res, 1995, 19: 595-603.
9Schnittger S, Meggendorfer M, Kohlmann A, et al. SRSF2 is mutated in 47.2% (77/163) of chronic myelomonocytic leukemia (CMML) and prognostically favorable in cases with concomitant RUNX 1 mutations. Blood, 2011,118:274 [ abstract ].
10Kar SA, Jankowska A, Makishima H, et al. SpliceosomaI gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia. Haematologica, 2013, 98: 107-113.
